Pacific Biopharmaceuticals

Pacific Biopharmaceuticals is a Malaysia-based biopharmaceutical company specializing in the development, manufacturing, and commercialization of vaccines and biologics, with a core focus on the global halal market. The company is currently developing a large-scale manufacturing facility in the Enstek Industrial Park to produce essential vaccines, including those for HPV, Influenza, and Hepatitis B. Through a strategic partnership with Sinovac Biotech, Pacific Biopharmaceuticals is facilitating the technology transfer for a 9-valent HPV vaccine and a tetravalent influenza vaccine, both targeted for regional distribution. The company’s pipeline also includes programs for Hepatitis B and Polio, aimed at strengthening health security and vaccine self-sufficiency in Southeast Asia. By leveraging international collaborations and state-of-the-art infrastructure, Pacific Biopharmaceuticals aims to become a leading hub for vaccine innovation and halal-certified pharmaceutical products globally.